Genetic Structure Determined for Pathogenic Spirochete
By LabMedica International staff writers Posted on 27 Oct 2010 |
Image: Colored scanning electron micrograph (SEM) of a conglomeration of Borrelia burgdorferi bacteria, cause of Lyme disease in humans (photo courtesy Juergen Berger / Science Photo Library).
The complete genetic structures of 13 strains of the bacteria that cause Lyme disease have been resolved.
Lyme disease is the most frequent tick-borne disease in North America and Europe. There are multiple variants of Borrelia burgdorferi, the causative agent, but questions remain about how their variation correlates with different clinical manifestations.
A single genome sequence is not sufficient to understand the relationship between genotypic and geographic variation and disease phenotype. In a collaborative study carried out at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, (UMDNJ; Newark, NJ, USA), the whole genome sequence of 13 different isolates that span the range of natural variation has been determined. The strains were isolated from human and other natural sources.
New insights into Lyme disease are needed. While the bacterium that causes the disease has been known for 27 years, there still is no vaccine for humans available. The authors believe that their sequence information will help investigators design improved diagnostic tests and vaccines. Efficient tests are needed because the telltale rash on the skin does not always appear in infected patients. Cultures, which work well for many other bacteria, take too long to be of immediate use for Lyme bacteria. Serological and DNA assays have proven to be unsatisfactory. Therefore, these sequences should allow improved understanding of pathogenesis and provide a foundation for novel detection, diagnosis, and prevention strategies.
These new discoveries may accelerate research efforts to diagnose, prevent, and treat the disease, which can affect the nervous system, heart, skin, and joints. The occurrence of the disease has grown dramatically over the past ten years in the U.S. and Europe. There were nearly 30,000 new cases of Lyme disease reported in the U.S. in 2009, and cases have increased by 90% in the U.K.
Steven E. Schutzer, M.D., the senior author of the study, said, "A driving force for doing this project was the observation that certain forms of the bacteria can be more invasive than others. We wanted to find out why and how to identify this property".
The study was published in October 2010 in the Journal of Bacteriology.
Related Links:
University of Medicine and Dentistry of New Jersey
Lyme disease is the most frequent tick-borne disease in North America and Europe. There are multiple variants of Borrelia burgdorferi, the causative agent, but questions remain about how their variation correlates with different clinical manifestations.
A single genome sequence is not sufficient to understand the relationship between genotypic and geographic variation and disease phenotype. In a collaborative study carried out at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, (UMDNJ; Newark, NJ, USA), the whole genome sequence of 13 different isolates that span the range of natural variation has been determined. The strains were isolated from human and other natural sources.
New insights into Lyme disease are needed. While the bacterium that causes the disease has been known for 27 years, there still is no vaccine for humans available. The authors believe that their sequence information will help investigators design improved diagnostic tests and vaccines. Efficient tests are needed because the telltale rash on the skin does not always appear in infected patients. Cultures, which work well for many other bacteria, take too long to be of immediate use for Lyme bacteria. Serological and DNA assays have proven to be unsatisfactory. Therefore, these sequences should allow improved understanding of pathogenesis and provide a foundation for novel detection, diagnosis, and prevention strategies.
These new discoveries may accelerate research efforts to diagnose, prevent, and treat the disease, which can affect the nervous system, heart, skin, and joints. The occurrence of the disease has grown dramatically over the past ten years in the U.S. and Europe. There were nearly 30,000 new cases of Lyme disease reported in the U.S. in 2009, and cases have increased by 90% in the U.K.
Steven E. Schutzer, M.D., the senior author of the study, said, "A driving force for doing this project was the observation that certain forms of the bacteria can be more invasive than others. We wanted to find out why and how to identify this property".
The study was published in October 2010 in the Journal of Bacteriology.
Related Links:
University of Medicine and Dentistry of New Jersey
Latest Molecular Diagnostics News
- Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings
- Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’
- Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear
- Integrating Multiple Protein Markers Predicts Health Outcomes in Chronic Kidney Disease Patients
- Rapid Finger Prick Blood Test to Detect Active Syphilis at Point of Care
- Urine Tests Could Reveal Early Signs of Cancer and Other Diseases
- AI-Powered Smart PCR System to Revolutionize Clinical Diagnostics
- Simple Blood Test Identifies Women in Labor at Risk for Preeclampsia
- Point-Of-Care Paper-Based Test Could Diagnose Cancer at Bedside
- Sepsis Test Demonstrates Clinical Utility in Critically Ill Heterogeneous Patient Populations
- Multi-Cancer Early Detection Test Measures Host Response to Tumor Development
- MicroRNA-Based Test Identifies 12 Cancers Simultaneously Across Any Stage
- New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease
- First-Ever Blood Test Diagnoses Maternal Autoantibody Related Autism
- Precision Medicine Blood Test Predicts Heart Disease Before It Occurs
- Blood-Based PCR Test Guides Alzheimer's Therapy